Mesirow Financial Investment Management Equity Management increased its holdings in shares of HealthSouth Corporation (NYSE:HLS) by 8.9% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 38,150 shares of the company’s stock after purchasing an additional 3,115 shares during the period. Mesirow Financial Investment Management Equity Management’s holdings in HealthSouth Corporation were worth $1,769,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. First Mercantile Trust Co. grew its stake in HealthSouth Corporation by 18.8% during the second quarter. First Mercantile Trust Co. now owns 2,720 shares of the company’s stock worth $132,000 after purchasing an additional 430 shares during the period. Acrospire Investment Management LLC grew its stake in HealthSouth Corporation by 64.7% during the second quarter. Acrospire Investment Management LLC now owns 2,800 shares of the company’s stock worth $136,000 after purchasing an additional 1,100 shares during the period. Advisor Group Inc. grew its stake in HealthSouth Corporation by 33.8% during the second quarter. Advisor Group Inc. now owns 3,092 shares of the company’s stock worth $149,000 after purchasing an additional 781 shares during the period. Petrus Trust Company LTA acquired a new stake in HealthSouth Corporation during the second quarter worth approximately $210,000. Finally, HL Financial Services LLC bought a new position in HealthSouth Corporation in the second quarter worth approximately $213,000. 93.11% of the stock is owned by institutional investors and hedge funds.

COPYRIGHT VIOLATION NOTICE: This article was first reported by Watch List News and is owned by of Watch List News. If you are reading this article on another site, it was illegally stolen and reposted in violation of U.S. and international copyright legislation. The original version of this article can be viewed at https://www.watchlistnews.com/healthsouth-corporation-hls-position-raised-by-mesirow-financial-investment-management-equity-management/1675683.html.

Several brokerages have issued reports on HLS. Mizuho increased their price target on HealthSouth Corporation from $44.00 to $47.00 and gave the stock a “neutral” rating in a report on Monday, July 10th. ValuEngine upgraded HealthSouth Corporation from a “hold” rating to a “buy” rating in a report on Friday, July 7th. Robert W. Baird reiterated a “buy” rating and issued a $55.00 price target on shares of HealthSouth Corporation in a report on Monday, October 9th. Zacks Investment Research lowered HealthSouth Corporation from a “buy” rating to a “hold” rating in a report on Tuesday. Finally, BidaskClub lowered HealthSouth Corporation from a “hold” rating to a “sell” rating in a report on Thursday, July 13th. Two investment analysts have rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the stock. HealthSouth Corporation presently has a consensus rating of “Hold” and an average price target of $51.75.

In related news, CEO Mark J. Tarr sold 22,625 shares of the company’s stock in a transaction that occurred on Monday, August 7th. The stock was sold at an average price of $43.00, for a total value of $972,875.00. Following the transaction, the chief executive officer now directly owns 283,134 shares of the company’s stock, valued at approximately $12,174,762. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Yvonne M. Curl acquired 1,000 shares of the stock in a transaction that occurred on Wednesday, November 1st. The stock was acquired at an average cost of $45.95 per share, for a total transaction of $45,950.00. Following the completion of the transaction, the director now directly owns 64,144 shares in the company, valued at approximately $2,947,416.80. The disclosure for this purchase can be found here. Corporate insiders own 1.60% of the company’s stock.

HealthSouth Corporation (NYSE:HLS) last released its quarterly earnings data on Thursday, October 26th. The company reported $0.66 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.65 by $0.01. The business had revenue of $995.60 million for the quarter, compared to analysts’ expectations of $985.75 million. HealthSouth Corporation had a return on equity of 22.81% and a net margin of 6.69%. The firm’s quarterly revenue was up 7.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.65 EPS.

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, January 16th. Investors of record on Tuesday, January 2nd will be given a $0.25 dividend. The ex-dividend date of this dividend is Friday, December 29th. This represents a $1.00 annualized dividend and a yield of 2.07%. HealthSouth Corporation’s dividend payout ratio (DPR) is presently 36.36%.

About HealthSouth Corporation

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Want to see what other hedge funds are holding HLS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthSouth Corporation (NYSE:HLS).

Institutional Ownership by Quarter for HealthSouth Corporation (NYSE:HLS)

Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.